Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma
-
Benralizumab receives positive EU CHMP opinion for severe, uncontrolled eosinophilic asthma
-
Year-To-Date and Q3 2017 Results
-
AstraZeneca shares scientific updates from its extensive cardiovascular, renal and metabolic diseases (CVMD) portfolio at AHA 2017
-
AstraZeneca provides update on tralokinumab Phase III programme in severe, uncontrolled asthma
-
US FDA approves AstraZeneca’s Calquence (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma
-
AstraZeneca and Incyte enter clinical trial collaboration in early lung cancer
-
AstraZeneca and MSD rapidly advance Lynparza in Japan with a second regulatory submission
-
US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type-2 diabetes
-
US FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority Review
Latest articles and press releases
All of our latest press releases and articles are available to explore
